NCT05494801View on ClinicalTrials.gov

Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III

CompletedOBSERVATIONAL

Enrollment

203

Participants

Timeline

Start Date

August 25, 2022

Primary Completion Date

March 25, 2023

Study Completion Date

March 25, 2023

Conditions

Ebola Virus Disease

Trial Locations (1)

Unknown

John F. Kennedy Medical Center, Monrovia

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH